Dordaviprone CAS# 1616632-77-9 2,4,6,7,8,9-六氢-4-[(2-甲基苯基)甲基]-7-苄基咪唑并[1,2-a]吡啶并[3,4-e]嘧啶-5(1H)-酮

Dordaviprone, also known as ONC-201 and TIC10, is a potent, orally active, and stable small molecule that transcriptionally induces TRAIL in a p53-independent manner and crosses the blood-brain barrier. TIC10 induces a sustained up-regulation of TRAIL in tumors and normal cells that may contribute to the demonstrable antitumor activity of TIC10. TIC10 inactivates kinases Akt and extracellular signal-regulated kinase (ERK), leading to the translocation of Foxo3a into the nucleus, where it binds to the TRAIL promoter to up-regulate gene transcription. TIC10 is an efficacious antitumor therapeutic agent that acts on tumor cells and their microenvironment to enhance the concentrations of the endogenous tumor suppressor TRAIL.